Skip to content
An Initiative of AVAC
Search
Back to Data by Country

Country Overview:
France

Global PrEP Tracker
Last Updated: 30 November 2022

Drug Registration Status

Approved
Not
Approved
Under
Review
Data not
available
Gilead's Truvada (TDF/FTC) Registration
Approved
Generic versions of TDF/FTC for prevention
Approved
Viiv's Apretude (CAB for PrEP) Registration
Under Review
IPM's Dapivirine Vaginal Ring Registration
Not Approved
Oral F/TAF (Descovy) Registration
Not Approved

Research, Demonstration and Implementation

Oral PrEP

N/A Completed Projects

Dapivirine Vaginal Ring

N/A Planned/Ongoing Projects

Injectable PrEP

1 Planned/Ongoing Projects

Policy Frameworks

France Interim PrEP Guidelines in the Context of COVID, 2021

National Strategic Road Map for Sexual Health, 2021-24

Est. Cumulative
Initiations:

Total PrEP: 46,706

Oral PrEP: 46,706

Dapivirine Vaginal Ring: N/A

Injectable PrEP: N/A

PEPFAR Targets in
COP 2022:

Total PrEP: N/A

Oral PrEP: N/A

Dapivirine Vaginal Ring: N/A

Injectable PrEP: N/A

Featured Resources

Document

Ending the HIV Epidemic France, 2019

An assessment of HIV policy in France and recommendations to improve the lives of those living with, and at risk of HIV.
Document

HIV PrEP in the EU/EEA and the UK: Implementation, Standards & Monitoring, 2021

This guidance was developed to support EU/EEA countries in their efforts to curb the HIV epidemic and to harmonise the overall approach to PrEP implementation in the region. It has been developed through evidence synthesis, online stakeholder consultation with experts with community, clinical and/or public health or policy- making expertise and through ongoing engagement and…
View All Resources